Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Puma Biotechnology (PBYI) Inventory Average: 2017-2025

Historic Inventory Average for Puma Biotechnology (PBYI) over the last 8 years, with Sep 2025 value amounting to $9.0 million.

  • Puma Biotechnology's Inventory Average rose 54.13% to $9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.0 million, marking a year-over-year increase of 54.13%. This contributed to the annual value of $7.9 million for FY2024, which is 36.17% up from last year.
  • Per Puma Biotechnology's latest filing, its Inventory Average stood at $9.0 million for Q3 2025, which was up 4.18% from $8.7 million recorded in Q2 2025.
  • In the past 5 years, Puma Biotechnology's Inventory Average ranged from a high of $9.0 million in Q3 2025 and a low of $4.2 million during Q1 2023.
  • Over the past 3 years, Puma Biotechnology's median Inventory Average value was $6.7 million (recorded in 2023), while the average stood at $6.9 million.
  • In the last 5 years, Puma Biotechnology's Inventory Average skyrocketed by 148.30% in 2021 and then plummeted by 41.49% in 2023.
  • Quarterly analysis of 5 years shows Puma Biotechnology's Inventory Average stood at $7.2 million in 2021, then tumbled by 30.30% to $5.0 million in 2022, then increased by 27.87% to $6.4 million in 2023, then declined by 10.67% to $5.7 million in 2024, then spiked by 54.13% to $9.0 million in 2025.
  • Its last three reported values are $9.0 million in Q3 2025, $8.7 million for Q2 2025, and $8.7 million during Q1 2025.